{"Title": ["BUZZ-U.S. STOCKS ON THE MOVE-Ideanomics, Document Security Systems, Fuelcell Energy", "BUZZ-U.S. STOCKS ON THE MOVE-Yum China, Chegg, Koppers, CoreCivic", "BUZZ-U.S. STOCKS ON THE MOVE-Beyond Meat, BioSig Technologies, The Alkaline Water Co", "BUZZ-U.S. STOCKS ON THE MOVE-Energous Corp,Norwegian Cruise Line, Aclaris Therapeutics", "BUZZ-U.S. STOCKS ON THE MOVE-Red Robin Gourmet Burgers, Royalty Pharma, Oracle Corp", "BUZZ-U.S. STOCKS ON THE MOVE-U.S. Retailers, T-Mobile, Aveo Pharmaceuticals", "After Market Hours: ClearSign Tech, WW Int'l, Mid-Con Gains; Huntington, AVEO Slip", "EYEG Catches Eyes, KNSA & COVID-19, VVUS Gains Weight On Launch Of Telemedicine", "BUZZ-U.S. STOCKS ON THE MOVE-Ideanomics, Document Security Systems, Fuelcell Energy", "AVEO Pharmaceuticals (AVEO) Dips More Than Broader Markets: What You Should Know", "AVEO Pharmaceuticals (AVEO) Outpaces Stock Market Gains: What You Should Know", "5 Top Gainers In Healthcare Sector (AVEO, EDAP, ZYNE...)", "AVEO Pharmaceuticals (AVEO) to File NDA for Fotivda with FDA", "Mid-Afternoon Market Update: Shoe Carnival Surges On Upbeat Q4 Results; Inpixon Shares Plunge", "Mid-Day Market Update: Crude Oil Down Over 1%; Syndax Pharmaceuticals Shares Spike Higher", "AVEO (AVEO) Upgraded to Buy: What Does It Mean for the Stock?", "FDA Says \"Not Now AVEO\", HALO Axes 160 Jobs, RDHL Gets Nod For H.pylori Drug", "The Zacks Analyst Blog Highlights: Gilead, Vertex, Celgene, Alkermes and AVEO", "Biotech Stock Roundup: Celgene Tops in Q4, Gilead Disappoints, ALKS & AVEO Sink", "AVEO Oncology Plunges on Delay in Filing Fotivda NDA With FDA", "Why AVEO Oncology Stock Is Crashing Today", "Options Traders Expect Huge Moves in AVEO Pharmaceuticals (AVEO) Stock", "Here's Why These Small-Cap Pharma Stocks Lost as Much as 45% in December", "Do Options Traders Know Something About AVEO Pharmaceuticals (AVEO) Stock We Don't?", "AVEO Pharmaceuticals (AVEO) Q4 Earnings Beat, Revenues Lag", "Why AVEO Pharmaceuticals Stock Tanked Last Month", "Mid-Day Market Update: Crude Oil Down 5.5%; Bioblast Pharma Shares Spike Higher", "Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options", "Health Care Sector Update for 11/15/2018: QURE, EXEL, AVEO, JNJ, PFE, MRK, ABT, AMGN", "AVEO Pharmaceuticals (AVEO) Q3 Earnings & Revenues Top Mark", "AVEO Pharmaceuticals (AVEO) Reports Q3 Loss, Tops Revenue Estimates", "Noteworthy Monday Option Activity: IBM, AVEO, FRPT", "5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride", "5 \u2018Strong Buy\u2019 Stocks Under $10", "Why AVEO Pharmaceuticals, Inc. Stock Perked Up in September", "Do Options Traders Know Something About AVEO Stock We Don't?", "Why AVEO Pharmaceuticals Inc. Rocketed Higher Today", "Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options", "AVEO (AVEO) Up 25.3% Since Last Earnings Report: Can It Continue?", "Here's Why AVEO Pharmaceuticals Inc. Jumped 40% Higher in August", "Analysts Estimate AVEO Pharmaceuticals (AVEO) to Report a Decline in Earnings: What to Look Out for", "5 \u2018Strong Buy\u2019 Stocks Under $10", "Here's Why AVEO Pharmaceuticals Inc. Jumped Today", "AVEO Pharmaceuticals (AVEO) Soars: Stock Adds 11.8% in Session", "Here's Why AVEO Pharmaceuticals Inc. Plummeted Today Without Issuing a Press Release", "Noteworthy Tuesday Option Activity: MRK, AVEO, TROX", "Do Options Traders Know Something About AVEO Pharmaceuticals (AVEO) Stock We Don't?", "Aveo Stock Breaks Out After Strong Drug Results and a Modest Offering", "AVEO Pharmaceuticals (AVEO) Q1 Loss Wider Than Expected", "Here's Why AVEO Pharmaceuticals Fell as Much as 17% Today", "AVEO Pharmaceuticals (AVEO) Q1 Earnings: What's in Store?", "Options Traders Expect Huge Moves in AVEO Pharmaceuticals (AVEO) Stock", "AVEO Down 7.7% Since Earnings Report: Can It Rebound?", "Why AVEO Oncology Jumped Higher Today", "Moving Average Crossover Alert: AVEO Pharmaceuticals, Inc. (AVEO)", "Why Is AVEO Pharmaceuticals (AVEO) Down 1.6% Since Its Last Earnings Report?", "AVEO Pharmaceuticals (AVEO) Q4 Loss Widens, Shares Down", "AVEO Pharmaceuticals (AVEO) Q4 Loss Wider, Revenues Miss", "AVEO Pharmaceuticals' (AVEO) Q4 Earnings: What's in Store?", "AVEO (AVEO) to Get $2 Million from EUSA Pharma for Fotivda", "Health Care Sector Update for 02/12/2018: JNJ, PFE, ABT, MRK, AMGN, AXON, ZIOP, FOLD, PTN, AVEO, ROG.VX", "Health Care Sector Update for 02/12/2018: AXON,UTHR,NVO,FOLD,AVEO", "Health Care Sector Update for 02/12/2018: AXON,UTHR,NVO,FOLD,AVEO", "Options Traders Expect Huge Moves in AVEO Pharmaceuticals (AVEO) Stock", "AVEO Pharmaceuticals Q3 Loss Narrows, Focus on Fotivda", "Why AVEO Pharmaceuticals, Inc. Tanked 18.6% in October", "Is AVEO Pharmaceuticals Poised for a Beat in Q3 Earnings?", "3 Biotech Stocks That Turned $1,000 Into More Than $5,000 This Year", "Here's Why AVEO Pharmaceuticals Dropped as Much as 16.3% Today", "Here's Why AVEO Pharmaceuticals Lost as Much as 19% Today", "Health Care Sector Update for 08/28/2017: AVEO,TNDM,CDNA", "Here's Why AVEO Oncology Rose as Much as 13.7% Today", "AVEO Pharmaceuticals (AVEO) Q2 Earnings: What's in Store?", "Here's Why AVEO Oncology Rose as Much as 15% Today", "Here's Why AVEO Oncology Fell as Much as 12.7% Today", "Company News for July 10, 2017", "AVEO Pharmaceuticals (AVEO) Worth a Look: Stock Up 14.8%", "Why AVEO Pharmaceuticals, Inc. (AVEO) Stock Is Soaring Today", "AVEO's Kidney Cancer Candidate Gets CHMP Recommendation", "AVEO Pharmaceuticals (AVEO) Q2 Loss Narrower than Expected", "AVEO Pharmaceuticals (AVEO) Q2 Earnings: What's in Store?", "Here's Why AVEO Oncology Rose as Much as 15% Today", "AVEO Reaches Enrollment Target in Pivotal Tivozanib Study", "Why Is AVEO Pharmaceuticals (AVEO) Up 25% Since the Last Earnings Report?", "Health Care Sector Update for 05/19/2017: AVEO,GLYC,CLBS", "AVEO Pharmaceuticals (AVEO) Q1 Loss Narrower Than Expected", "AVEO Pharmaceuticals (AVEO) Down 17.4% Since Earnings Report: Can It Rebound?", "Here's Why AVEO Oncology Rose As Much As 13.8% Today", "AVEO (AVEO) Reports Narrower-than-Expected Loss in Q4", "AVEO Pharmaceuticals (AVEO) Q4 Earnings: What's in Store?", "GW Pharmaceuticals (GWPH): What Awaits in Q4 Earnings?", "AVEO Partner Submits Response to Questions on Tivozanib", "AVEO Pharmaceuticals' (AVEO) Q3 Loss Lower than Expected", "AVEO (AVEO) Reports Narrower-than-Expected Loss in Q3", "AVEO Pharmaceuticals (AVEO) Q3 Earnings: What's in Store?", "Health Care Sector Update for 04/13/2017: AVEO", "5 Biotech Stocks That Are Broker Favorites", "The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen", "Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data", "AVEO (AVEO) Reports a Wider Loss in Q2, Tivozanib in Focus", "AVEO (AVEO) Reports Narrower-than-Expected Loss in Q2", "Will AVEO (AVEO) Pull a Surprise This Earnings Season?", "AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 10.4%", "AVEO Pharmaceuticals (AVEO) Sees Hammer Chart Pattern: Time to Buy?", "5 Biotech Stocks That Are Broker Favorites", "The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen", "Health Care Sector Update for 06/01/2016: EVOK,AVEO,APHB", "Health Care Sector Update for 06/01/2016: INNL,AVEO,APHB", "AVEO Q1 Loss In Line with Expectation, Tivozanib in Focus", "Will AVEO Pharmaceuticals (AVEO) Surprise in Q1 Earnings?", "AVEO Gives AV-203 Ex-U.S. Rights to CANbridge Life Sciences", "Buy 5 Attractive Biotechs at Bargain Prices", "AVEO (AVEO) Reports Narrower-than-Expected Loss in Q4", "Will AVEO (AVEO) Surprise Estimates in Q4 Earnings Again?", "The Zacks Analyst Blog Highlights: Gilead, Horizon Pharma, AVEO Pharmaceuticals, Achillion Pharmaceuticals and Inovio Pharmaceuticals", "AVEO Licenses Tivozanib European Rights to EUSA Pharma", "Health Care Sector Update for 12/21/2015: AVEO,CAPN,KBIO", "AVEO (AVEO) Swings into Earnings in Q3, Revenues Up Y/Y", "Will AVEO (AVEO) Pull a Surprise this Earnings Season?", "AVEO Q4 Loss Narrower than Expected, Tivozanib in Focus", "AVEO Up on Novartis Collaboration for Cachexia Candidate", "Pre-Market Most Active for Aug 17, 2015 : AVEO, ZU, ARMH, TSLA, AAPL, ALV, FCX, QQQ, PSO, TWTR, SDRL, NOK", "Monday Sector Leaders: Precious Metals, Drugs", "AVEO Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog", "AVEO (AVEO) Reports Narrower-than-Expected Loss in Q2 - Tale of the Tape", "What Awaits AVEO Pharmaceuticals (AVEO) in Q2 Earnings? - Analyst Blog", "Health Care Sector Update for 06/12/2015: AVEO,TNXP,AGIO", "AVEO Pharmaceuticals (AVEO) in Focus: Stock Soars 45.3%", "Pre-Market Most Active for Jun 4, 2015 : AER, AVEO, T, DISH, S, VZ, TMUS, OPK, VWR, FB, XIV, AAPL", "Pre-Market Most Active for Jun 2, 2015 : FTR, AVEO, BXMT, UN, ERIC, FCAU, AAPL, DNR, XIV, QQQ, SDRL, SAN", "Pre-Market Most Active for May 22, 2015 : ONTY, PBMD, RIO, FCAU, STM, ALU, RDS/B, VOD, AVEO, AAPL, NOK, BBRY", "Health Care Sector Update for 05/07/2015: AVEO, ACHN, HZNP", "AVEO Pharmaceuticals' (AVEO) Q1 Loss Narrower than Expected - Tale of the Tape", "Will AVEO Pharmaceuticals (AVEO) Surprise This Earnings? - Analyst Blog", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "AVEO Pharmaceuticals (AVEO) Jumps: Stock Moves Up 7.3% - Tale of the Tape", "Sanofi's (SNY) Basal Insulin Toujeo Gains European Approval - Analyst Blog", "Aeterna Zentaris to Continue Phase III Study of Cancer Drug - Analyst Blog", "BioMarin Upgraded to Strong Buy, Is It in Your Portfolio? - Analyst Blog", "Hospira, Set to Be Acquired by Pfizer, Beats on Q1 Earnings - Analyst Blog", "RedHill Finishes Patient Enrollment for RHB-105 Study - Analyst Blog", "Celladon's Advanced Heart Failure Study Fails, Shares Crash - Analyst Blog", "Aerie (AERI) Plunges on Disappointing Rhopressa Data - Analyst Blog", "United Therapeutics Falls on Q1 Loss, Misses on Revenues - Analyst Blog", "Biogen Misses on 1Q Earnings, Tecfidera Falls Short - Analyst Blog", "AbbVie's HCV Cocktail Treatment Under FDA Priority Review - Analyst Blog", "Eli Lilly Beats on 1Q Earnings by Wide Margin, Affirms View - Analyst Blog", "Alexion Misses Q1 Earnings Estimates, Keeps 2015 Outlook - Analyst Blog", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Isis Pharmaceuticals' ISIS-TTR Effective in Extension Study - Analyst Blog", "Acorda Reports Encouraging Data on MS Drug - Analyst Blog", "Eli Lilly's Cyramza Gains FDA Approval for Label Expansion - Analyst Blog", "Capricor's CAP-1002 Gets Orphan Drug Status in the U.S. - Analyst Blog", "Ultragenyx Announces Positive Data from Triheptanoin Study - Analyst Blog", "AVEO Pharmaceuticals (AVEO) Shares March Higher, Can It Continue? - Tale of the Tape", "The Medicines Co.'s New Minocin Formulation Approved - Analyst Blog", "Bristol-Myers Announces Positive Data from Opdivo Study - Analyst Blog", "Actavis' Botox Upper Limb Spasticity Label Expanded by FDA - Analyst Blog", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Emergent BioSolutions Resumes BioThrax Manufacturing - Analyst Blog", "Athersys Slumps as MultiStem Fails in Mid-Stage Study - Analyst Blog", "Bristol-Myers' Study on Opdivo Halted on Early Success - Analyst Blog", "Oncolytics' Reolysin Gets One More Orphan Drug Status - Analyst Blog", "TrovaGene's (TROV) PCM Data Impresses, Shares Rally - Analyst Blog", "AVEO Pharmaceuticals (AVEO) Jumps: Stock Moves Up 16.2% - Tale of the Tape", "Receptos Gains on Positive Phase II Data on Ozanimod - Analyst Blog", "AstraZeneca's Onglyza Label Needs Revision per FDA Panel - Analyst Blog", "Merck's Keytruda Tops Melanoma, Lung Cancer Studies - Analyst Blog", "Athersys Slumps as MultiStem Fails in Mid-Stage Study - Analyst Blog", "Bristol-Myers' Study on Opdivo Halted on Early Success - Analyst Blog", "Oncolytics' Reolysin Gets One More Orphan Drug Status - Analyst Blog", "TrovaGene's (TROV) PCM Data Impresses, Shares Rally - Analyst Blog", "AVEO Pharmaceuticals (AVEO) Jumps: Stock Moves Up 16.2% - Tale of the Tape", "AVEO Up on Pipeline News, Q4 Loss Narrower than Expected - Analyst Blog", "The Medicines Co.'s Kengreal Backed for FDA Approval - Analyst Blog", "Pre-Market Earnings Report for March 6, 2015 : SPLS, FL, BIG, CMRX, GPT, SXE, KVHI, MRCC, VTG, AVEO", "AVEO Gains on Tivozanib Agreement with Ophthotech - Analyst Blog", "Will AVEO Pharmaceuticals (AVEO) Surprise this Earnings? - Analyst Blog", "AVEO-Biodesix Reveal Lung Cancer Study Exploratory Data - Analyst Blog", "BioMed Leases Space to Baxter for R&D Center in MA - Analyst Blog", "AVEO Pharmaceuticals (AVEO) Shares March Higher, Can It Continue? - Tale of the Tape", "Tuesday Sector Laggards: Cigarettes & Tobacco, Drugs", "Health Care Sector Update for 03/09/2015: AVEO,HTBX,ACRX", "Can the Uptrend Continue for AVEO Pharmaceuticals (AVEO)? - Tale of the Tape", "AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 11.4% - Tale of the Tape", "AVEO Pharmaceuticals, Inc. (AVEO) in Focus: Stock Rises 7.8% - Tale of the Tape", "PTC Therapeutics Up on Positive CHMP Opinion - Analyst Blog", "Sarepta to Acquire Manufacturing Facility - Analyst Blog", "Narrower-than-Expected Loss at AVEO - Analyst Blog", "AVEO-Biodesix Ink Deal - Analyst Blog", "AVEO Pharmaceuticals (AVEO) Jumps: Stock Rises 6.4% - Tale of the Tape", "AVEO Regains AV-203 Rights from Biogen - Analyst Blog", "Healthcare Stocks Undercut Earlier Market Advance; Gilead Sciences Sinks After Congress Questions Drug Price", "AVEO Q4 Loss Narrower than Expected - Analyst Blog", "Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog", "AVEO/Astellas Terminate Agreement - Analyst Blog", "AVEO/Astellas Terminate Tivozanib Trial - Analyst Blog", "AVEO Pharmaceuticals, Inc. (AVEO) Catches Eye: Stock Rises 8% - Tale of the Tape", "AVEO Pharmaceuticals (AVEO) Jumps: Stock Rises 7.2% - Tale of the Tape", "AVEO Regains AV-203 Rights from Biogen - Analyst Blog", "Wild Card Wonders, Shopping for 52-Week Lows", "Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low", "Merrimack: Undervalued Because Of Misunderstanding And Miscommunication?", "AVEO Pharma Cuts Q2 Loss - Analyst Blog", "Sector Update: Healthcare Shares Higher; Stereotaxis Drops 43% On Q2 Results", "Sector Update: Healthcare", "AVEO Falls on Tivozanib News - Analyst Blog", "AVEO Q3 Loss Wider than Expected, Shares Down - Analyst Blog", "Wild Card Wonders, Shopping for 52-Week Lows", "Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low", "Merrimack: Undervalued Because Of Misunderstanding And Miscommunication?", "AVEO Pharma Cuts Q2 Loss - Analyst Blog", "Sector Update: Healthcare Shares Higher; Stereotaxis Drops 43% On Q2 Results", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "CRL for AVEO/ALPMY's Tivozanib - Analyst Blog", "Zacks #1 Rank Additions for Wednesday - Tale of the Tape", "XOMA Enrolls for Gevokizumab Trials - Analyst Blog", "AVEO's AV-203 in Phase I - Analyst Blog", "Bearish MACD for AVEO Pharmaceuticals, Inc. - Tale of the Tape", "Are Analysts Too Optimistic About These Stocks? Short Sellers Think So", "2 Picks from an Investment Pro with 20% Annual Gains", "The Top 12 IPOs of 2010 -- Can They Go Higher?", "Zacks #1 Rank Additions for Wednesday - Tale of the Tape"], "Elapsed Time": ["JUN 17, 2020", "JUN 17, 2020", "JUN 17, 2020", "JUN 17, 2020", "JUN 16, 2020", "JUN 16, 2020", "JUN 15, 2020", "APR 1, 2020", "JUN 17, 2020", "APR 15, 2019", "APR 8, 2019", "APR 2, 2019", "MAR 29, 2019", "MAR 27, 2019", "MAR 27, 2019", "MAR 19, 2019", "NOV 5, 2019", "FEB 7, 2019", "FEB 6, 2019", "FEB 1, 2019", "JAN 31, 2019", "JAN 23, 2019", "JAN 10, 2019", "DEC 20, 2018", "MAR 15, 2019", "DEC 10, 2018", "NOV 20, 2018", "NOV 20, 2018", "NOV 15, 2018", "NOV 12, 2018", "NOV 9, 2018", "NOV 5, 2018", "DEC 14, 2018", "OCT 12, 2018", "OCT 10, 2018", "OCT 9, 2018", "SEP 25, 2018", "SEP 10, 2018", "SEP 6, 2018", "SEP 5, 2018", "OCT 30, 2018", "OCT 12, 2018", "JUL 23, 2018", "JUL 20, 2018", "JUL 17, 2018", "JUL 10, 2018", "JUN 8, 2018", "AUG 30, 2018", "MAY 9, 2018", "MAY 8, 2018", "APR 30, 2018", "APR 23, 2018", "APR 12, 2018", "APR 9, 2018", "APR 5, 2018", "JUN 7, 2018", "MAR 14, 2018", "MAR 13, 2018", "MAR 6, 2018", "FEB 14, 2018", "FEB 12, 2018", "FEB 12, 2018", "FEB 12, 2018", "MAR 23, 2018", "NOV 8, 2017", "NOV 7, 2017", "OCT 31, 2017", "OCT 29, 2017", "OCT 17, 2017", "AUG 29, 2017", "AUG 28, 2017", "JAN 12, 2018", "JUL 26, 2017", "JUL 19, 2017", "JUL 11, 2017", "JUL 10, 2017", "JUL 10, 2017", "JUL 7, 2017", "JUN 27, 2017", "AUG 10, 2017", "JUL 26, 2017", "JUL 19, 2017", "JUN 21, 2017", "JUN 9, 2017", "MAY 19, 2017", "MAY 5, 2017", "APR 24, 2017", "JUN 27, 2017", "MAR 23, 2017", "MAR 6, 2017", "DEC 1, 2016", "NOV 29, 2016", "NOV 7, 2016", "NOV 4, 2016", "NOV 1, 2016", "APR 13, 2017", "SEP 13, 2016", "AUG 18, 2016", "AUG 17, 2016", "AUG 5, 2016", "AUG 4, 2016", "AUG 3, 2016", "JUL 22, 2016", "SEP 26, 2016", "SEP 13, 2016", "JUN 8, 2016", "JUN 1, 2016", "JUN 1, 2016", "MAY 11, 2016", "MAY 3, 2016", "MAR 23, 2016", "JUL 5, 2016", "MAR 15, 2016", "MAR 2, 2016", "JAN 12, 2016", "DEC 22, 2015", "DEC 21, 2015", "NOV 10, 2015", "NOV 2, 2015", "MAR 16, 2016", "AUG 18, 2015", "AUG 17, 2015", "AUG 17, 2015", "AUG 11, 2015", "AUG 10, 2015", "AUG 6, 2015", "JUN 12, 2015", "AUG 18, 2015", "JUN 4, 2015", "JUN 2, 2015", "MAY 22, 2015", "MAY 7, 2015", "MAY 7, 2015", "MAY 5, 2015", "MAY 4, 2015", "JUN 5, 2015", "APR 29, 2015", "APR 29, 2015", "APR 29, 2015", "APR 28, 2015", "APR 28, 2015", "APR 28, 2015", "APR 27, 2015", "APR 29, 2015", "APR 24, 2015", "APR 24, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 27, 2015", "APR 23, 2015", "APR 23, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 20, 2015", "APR 23, 2015", "APR 20, 2015", "APR 20, 2015", "APR 20, 2015", "APR 20, 2015", "APR 17, 2015", "APR 17, 2015", "APR 16, 2015", "APR 20, 2015", "APR 20, 2015", "APR 20, 2015", "APR 20, 2015", "APR 20, 2015", "APR 17, 2015", "MAR 9, 2015", "APR 16, 2015", "MAR 5, 2015", "NOV 13, 2014", "NOV 5, 2014", "OCT 2, 2014", "SEP 30, 2014", "AUG 21, 2014", "JUL 15, 2014", "MAR 9, 2015", "JUN 26, 2014", "JUN 18, 2014", "JUN 10, 2014", "MAY 27, 2014", "MAY 23, 2014", "MAY 8, 2014", "APR 11, 2014", "JUL 1, 2014", "MAR 21, 2014", "MAR 21, 2014", "MAR 14, 2014", "FEB 19, 2014", "FEB 18, 2014", "JAN 31, 2014", "DEC 31, 2013", "MAR 24, 2014", "MAR 21, 2014", "SEP 28, 2013", "SEP 3, 2013", "AUG 15, 2013", "AUG 14, 2013", "AUG 8, 2013", "AUG 8, 2013", "DEC 16, 2013", "NOV 12, 2013", "SEP 28, 2013", "SEP 3, 2013", "AUG 15, 2013", "AUG 14, 2013", "DEC 16, 2012", "OCT 23, 2012", "JUN 12, 2013", "OCT 10, 2012", "JUL 6, 2012", "MAY 24, 2012", "MAY 7, 2012", "SEP 12, 2011", "FEB 22, 2011", "OCT 19, 2010", "OCT 17, 2012"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-ideanomics-document-security-systems-fuelcell-energy-2020-06", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-yum-china-chegg-koppers-corecivic-2020-06-17", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-beyond-meat-biosig-technologies-the-alkaline-water-co-2020-06", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-energous-corpnorwegian-cruise-line-aclaris-therapeutics-2020", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-red-robin-gourmet-burgers-royalty-pharma-oracle-corp-2020-06", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-u.s.-retailers-t-mobile-aveo-pharmaceuticals-2020-06-16", "https://www.nasdaq.com/articles/after-market-hours%3A-clearsign-tech-ww-intl-mid-con-gains-huntington-aveo-slip-2020-06-15", "https://www.nasdaq.com/articles/eyeg-catches-eyes-knsa-covid-19-vvus-gains-weight-on-launch-of-telemedicine-2020-04-01", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-ideanomics-document-security-systems-fuelcell-energy-2020-06", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-dips-more-than-broader-markets%3A-what-you-should-know-2019-04-0", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-outpaces-stock-market-gains%3A-what-you-should-know-2019-04-08-0", "https://www.nasdaq.com/articles/5-top-gainers-healthcare-sector-aveo-edap-zyne...-2019-04-02", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-to-file-nda-for-fotivda-with-fda-2019-03-29-0", "https://www.nasdaq.com/articles/mid-afternoon-market-update-shoe-carnival-surges-upbeat-q4-results-inpixon-shares-plunge", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-down-over-1-syndax-pharmaceuticals-shares-spike-higher", "https://www.nasdaq.com/articles/aveo-aveo-upgraded-to-buy%3A-what-does-it-mean-for-the-stock-2019-03-19", "https://www.nasdaq.com/articles/fda-says-not-now-aveo-halo-axes-160-jobs-rdhl-gets-nod-for-h.pylori-drug-2019-11-05", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-vertex-celgene-alkermes-and-aveo-2019-02-07", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-celgene-tops-in-q4-gilead-disappoints-alks-aveo-sink-2019-02-06", "https://www.nasdaq.com/articles/aveo-oncology-plunges-on-delay-in-filing-fotivda-nda-with-fda-2019-02-01", "https://www.nasdaq.com/articles/why-aveo-oncology-stock-crashing-today-2019-01-31", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-aveo-pharmaceuticals-aveo-stock-2019-01-23", "https://www.nasdaq.com/articles/heres-why-these-small-cap-pharma-stocks-lost-much-45-december-2019-01-10", "https://www.nasdaq.com/articles/do-options-traders-know-something-about-aveo-pharmaceuticals-aveo-stock-we-dont-2018-12-20", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q4-earnings-beat-revenues-lag-2019-03-15", "https://www.nasdaq.com/articles/why-aveo-pharmaceuticals-stock-tanked-last-month-2018-12-10", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-down-55-bioblast-pharma-shares-spike-higher-2018-11-20", "https://www.nasdaq.com/articles/implied-volatility-surging-for-aveo-pharmaceuticals-aveo-stock-options-2018-11-20", "https://www.nasdaq.com/articles/health-care-sector-update-11152018-qure-exel-aveo-jnj-pfe-mrk-abt-amgn-2018-11-15", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q3-earnings-revenues-top-mark-2018-11-12", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-reports-q3-loss-tops-revenue-estimates-2018-11-09", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-ibm-aveo-frpt-2018-11-05", "https://www.nasdaq.com/articles/5-biotech-stocks-set-bounce-back-19-after-rough-ride-2018-12-14", "https://www.nasdaq.com/articles/5-strong-buy-stocks-under-%2410-2018-10-12", "https://www.nasdaq.com/articles/why-aveo-pharmaceuticals-inc-stock-perked-september-2018-10-10", "https://www.nasdaq.com/articles/do-options-traders-know-something-about-aveo-stock-we-dont-2018-10-09", "https://www.nasdaq.com/articles/why-aveo-pharmaceuticals-inc-rocketed-higher-today-2018-09-25", "https://www.nasdaq.com/articles/implied-volatility-surging-for-aveo-pharmaceuticals-aveo-stock-options-2018-09-10", "https://www.nasdaq.com/articles/aveo-aveo-up-25.3-since-last-earnings-report%3A-can-it-continue-2018-09-06", "https://www.nasdaq.com/articles/heres-why-aveo-pharmaceuticals-inc-jumped-40-higher-august-2018-09-05", "https://www.nasdaq.com/articles/analysts-estimate-aveo-pharmaceuticals-aveo-to-report-a-decline-in-earnings%3A-what-to-look", "https://www.nasdaq.com/articles/5-strong-buy-stocks-under-%2410-2018-10-12", "https://www.nasdaq.com/articles/heres-why-aveo-pharmaceuticals-inc-jumped-today-2018-07-23", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-soars%3A-stock-adds-11.8-in-session-2018-07-20", "https://www.nasdaq.com/articles/heres-why-aveo-pharmaceuticals-inc-plummeted-today-without-issuing-press-release-2018-07", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-mrk-aveo-trox-2018-07-10", "https://www.nasdaq.com/articles/do-options-traders-know-something-about-aveo-pharmaceuticals-aveo-stock-we-dont-2018-06-08", "https://www.nasdaq.com/articles/aveo-stock-breaks-out-after-strong-drug-results-and-modest-offering-2018-08-30", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q1-loss-wider-than-expected-2018-05-09", "https://www.nasdaq.com/articles/heres-why-aveo-pharmaceuticals-fell-much-17-today-2018-05-08", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q1-earnings%3A-whats-in-store-2018-04-30", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-aveo-pharmaceuticals-aveo-stock-2018-04-23", "https://www.nasdaq.com/articles/aveo-down-7.7-since-earnings-report%3A-can-it-rebound-2018-04-12", "https://www.nasdaq.com/articles/why-aveo-oncology-jumped-higher-today-2018-04-09", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-aveo-pharmaceuticals-inc.-aveo-2018-04-05", "https://www.nasdaq.com/articles/why-is-aveo-pharmaceuticals-aveo-down-1.6-since-its-last-earnings-report-2018-06-07", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q4-loss-widens-shares-down-2018-03-14", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q4-loss-wider-revenues-miss-2018-03-13", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q4-earnings%3A-whats-in-store-2018-03-06", "https://www.nasdaq.com/articles/aveo-aveo-to-get-%242-million-from-eusa-pharma-for-fotivda-2018-02-14", "https://www.nasdaq.com/articles/health-care-sector-update-02122018-jnj-pfe-abt-mrk-amgn-axon-ziop-fold-ptn-aveo-rogvx-2018", "https://www.nasdaq.com/articles/health-care-sector-update-02122018-axonuthrnvofoldaveo-2018-02-12-0", "https://www.nasdaq.com/articles/health-care-sector-update-02122018-axonuthrnvofoldaveo-2018-02-12", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-aveo-pharmaceuticals-aveo-stock-2018-03-23", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-q3-loss-narrows-focus-on-fotivda-2017-11-08", "https://www.nasdaq.com/articles/why-aveo-pharmaceuticals-inc-tanked-186-october-2017-11-07", "https://www.nasdaq.com/articles/is-aveo-pharmaceuticals-poised-for-a-beat-in-q3-earnings-2017-10-31", "https://www.nasdaq.com/articles/3-biotech-stocks-turned-1000-more-5000-year-2017-10-29", "https://www.nasdaq.com/articles/heres-why-aveo-pharmaceuticals-dropped-much-163-today-2017-10-17", "https://www.nasdaq.com/articles/heres-why-aveo-pharmaceuticals-lost-much-19-today-2017-08-29", "https://www.nasdaq.com/articles/health-care-sector-update-08282017-aveotndmcdna-2017-08-28", "https://www.nasdaq.com/articles/heres-why-aveo-oncology-rose-much-137-today-2018-01-12", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q2-earnings%3A-whats-in-store-2017-07-26", "https://www.nasdaq.com/articles/heres-why-aveo-oncology-rose-much-15-today-2017-07-19", "https://www.nasdaq.com/articles/heres-why-aveo-oncology-fell-much-127-today-2017-07-11", "https://www.nasdaq.com/articles/company-news-for-july-10-2017-2017-07-10", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-worth-a-look%3A-stock-up-14.8-2017-07-10", "https://www.nasdaq.com/articles/why-aveo-pharmaceuticals-inc-aveo-stock-soaring-today-2017-07-07", "https://www.nasdaq.com/articles/aveos-kidney-cancer-candidate-gets-chmp-recommendation-2017-06-27", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q2-loss-narrower-than-expected-2017-08-10", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q2-earnings%3A-whats-in-store-2017-07-26", "https://www.nasdaq.com/articles/health-care-sector-update-06232017-aveocaraocul-2017-06-23", "https://www.nasdaq.com/articles/aveo-reaches-enrollment-target-in-pivotal-tivozanib-study-2017-06-21", "https://www.nasdaq.com/articles/why-is-aveo-pharmaceuticals-aveo-up-25-since-the-last-earnings-report-2017-06-09", "https://www.nasdaq.com/articles/health-care-sector-update-05192017-aveoglycclbs-2017-05-19", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q1-loss-narrower-than-expected-2017-05-05", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-down-17.4-since-earnings-report%3A-can-it-rebound-2017-04-24", "https://www.nasdaq.com/articles/heres-why-aveo-oncology-rose-much-138-today-2017-06-27", "https://www.nasdaq.com/articles/aveo-aveo-reports-narrower-than-expected-loss-in-q4-2017-03-23", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q4-earnings%3A-whats-in-store-2017-03-06", "https://www.nasdaq.com/articles/gw-pharmaceuticals-gwph%3A-what-awaits-in-q4-earnings-2016-12-01", "https://www.nasdaq.com/articles/aveo-partner-submits-response-to-questions-on-tivozanib-2016-11-29", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q3-loss-lower-than-expected-2016-11-07", "https://www.nasdaq.com/articles/aveo-aveo-reports-narrower-than-expected-loss-in-q3-2016-11-04", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q3-earnings%3A-whats-in-store-2016-11-01", "https://www.nasdaq.com/articles/health-care-sector-update-04132017-aveo-2017-04-13", "https://www.nasdaq.com/articles/5-biotech-stocks-are-broker-favorites-2016-09-13", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vertex-aurinia-aveo-and-amgen-2016-08-18", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-slips-study-halt-aurinia-plunges-lupus-data-2016-08-17", "https://www.nasdaq.com/articles/aveo-aveo-reports-a-wider-loss-in-q2-tivozanib-in-focus-2016-08-05", "https://www.nasdaq.com/articles/aveo-aveo-reports-narrower-than-expected-loss-in-q2-2016-08-04", "https://www.nasdaq.com/articles/will-aveo-aveo-pull-a-surprise-this-earnings-season-2016-08-03", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-catches-eye%3A-stock-up-10.4-2016-07-22", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-sees-hammer-chart-pattern%3A-time-to-buy-2016-09-26", "https://www.nasdaq.com/articles/5-biotech-stocks-are-broker-favorites-2016-09-13", "https://www.nasdaq.com/articles/will-aveo-pharmaceuticals-aveo-continue-to-surge-higher-2016-06-08", "https://www.nasdaq.com/articles/health-care-sector-update-06012016-evokaveoaphb-2016-06-01", "https://www.nasdaq.com/articles/health-care-sector-update-06012016-innlaveoaphb-2016-06-01", "https://www.nasdaq.com/articles/aveo-q1-loss-in-line-with-expectation-tivozanib-in-focus-2016-05-11", "https://www.nasdaq.com/articles/will-aveo-pharmaceuticals-aveo-surprise-in-q1-earnings-2016-05-03", "https://www.nasdaq.com/articles/aveo-gives-av-203-ex-u.s.-rights-to-canbridge-life-sciences-2016-03-23", "https://www.nasdaq.com/articles/buy-5-attractive-biotechs-at-bargain-prices-2016-07-05", "https://www.nasdaq.com/articles/aveo-aveo-reports-narrower-than-expected-loss-in-q4-2016-03-15", "https://www.nasdaq.com/articles/will-aveo-aveo-surprise-estimates-in-q4-earnings-again-2016-03-02", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-horizon-pharma-aveo-pharmaceuticals-achillion", "https://www.nasdaq.com/articles/aveo-licenses-tivozanib-european-rights-to-eusa-pharma-2015-12-22", "https://www.nasdaq.com/articles/health-care-sector-update-12212015-aveocapnkbio-2015-12-21", "https://www.nasdaq.com/articles/aveo-aveo-swings-into-earnings-in-q3-revenues-up-y-y-2015-11-10", "https://www.nasdaq.com/articles/will-aveo-aveo-pull-a-surprise-this-earnings-season-2015-11-02", "https://www.nasdaq.com/articles/aveo-q4-loss-narrower-than-expected-tivozanib-in-focus-2016-03-16", "https://www.nasdaq.com/articles/aveo-up-on-novartis-collaboration-for-cachexia-candidate-2015-08-18", "https://www.nasdaq.com/articles/pre-market-most-active-aug-17-2015-aveo-zu-armh-tsla-aapl-alv-fcx-qqq-pso-twtr-sdrl-nok", "https://www.nasdaq.com/articles/monday-sector-leaders-precious-metals-drugs-2015-08-17", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-posts-narrower-than-expected-loss-analyst-blog-2015-08-11", "https://www.nasdaq.com/articles/aveo-aveo-reports-narrower-than-expected-loss-in-q2-tale-of-the-tape-2015-08-10", "https://www.nasdaq.com/articles/what-awaits-aveo-pharmaceuticals-aveo-in-q2-earnings-analyst-blog-2015-08-06", "https://www.nasdaq.com/articles/health-care-sector-update-06122015-aveotnxpagio-2015-06-12", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-in-focus%3A-stock-soars-45.3-2015-08-18", "https://www.nasdaq.com/articles/pre-market-most-active-jun-4-2015-aer-aveo-t-dish-s-vz-tmus-opk-vwr-fb-xiv-aapl-2015-06-04", "https://www.nasdaq.com/articles/pre-market-most-active-jun-2-2015-ftr-aveo-bxmt-un-eric-fcau-aapl-dnr-xiv-qqq-sdrl-san", "https://www.nasdaq.com/articles/pre-market-most-active-may-22-2015-onty-pbmd-rio-fcau-stm-alu-rdsb-vod-aveo-aapl-nok-bbry", "https://www.nasdaq.com/articles/health-care-sector-update-05072015-aveo-achn-hznp-2015-05-07", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-q1-loss-narrower-than-expected-tale-of-the-tape-2015-05-07", "https://www.nasdaq.com/articles/will-aveo-pharmaceuticals-aveo-surprise-this-earnings-analyst-blog-2015-05-05", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2015-05-04", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-jumps%3A-stock-moves-up-7.3-tale-of-the-tape-2015-06-05", "https://www.nasdaq.com/articles/sanofis-sny-basal-insulin-toujeo-gains-european-approval-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/aeterna-zentaris-to-continue-phase-iii-study-of-cancer-drug-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/biomarin-upgraded-to-strong-buy-is-it-in-your-portfolio-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/hospira-set-to-be-acquired-by-pfizer-beats-on-q1-earnings-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/redhill-finishes-patient-enrollment-for-rhb-105-study-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/celladons-advanced-heart-failure-study-fails-shares-crash-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/aerie-aeri-plunges-on-disappointing-rhopressa-data-analyst-blog-2015-04-27", "https://www.nasdaq.com/articles/united-therapeutics-falls-on-q1-loss-misses-on-revenues-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/biogen-misses-1q-earnings-tecfidera-falls-short-analyst-blog-2015-04-24", "https://www.nasdaq.com/articles/abbvies-hcv-cocktail-treatment-under-fda-priority-review-analyst-blog-2015-04-24", "https://www.nasdaq.com/articles/eli-lilly-beats-1q-earnings-wide-margin-affirms-view-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/alexion-misses-q1-earnings-estimates-keeps-2015-outlook-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2015-04-23", "https://www.nasdaq.com/articles/isis-pharmaceuticals-isis-ttr-effective-in-extension-study-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/acorda-reports-encouraging-data-on-ms-drug-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/eli-lillys-cyramza-gains-fda-approval-for-label-expansion-analyst-blog-2015-04-27", "https://www.nasdaq.com/articles/capricors-cap-1002-gets-orphan-drug-status-in-the-u.s.-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/ultragenyx-announces-positive-data-from-triheptanoin-study-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-shares-march-higher-can-it-continue-tale-of-the-tape-2015-04-21", "https://www.nasdaq.com/articles/the-medicines-co.s-new-minocin-formulation-approved-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/bristol-myers-announces-positive-data-from-opdivo-study-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/actavis-botox-upper-limb-spasticity-label-expanded-by-fda-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2015-04-20", "https://www.nasdaq.com/articles/emergent-biosolutions-resumes-biothrax-manufacturing-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/athersys-slumps-as-multistem-fails-in-mid-stage-study-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/bristol-myers-study-on-opdivo-halted-on-early-success-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/oncolytics-reolysin-gets-one-more-orphan-drug-status-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/trovagenes-trov-pcm-data-impresses-shares-rally-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-jumps%3A-stock-moves-up-16.2-tale-of-the-tape-2015-04-17", "https://www.nasdaq.com/articles/receptos-gains-on-positive-phase-ii-data-on-ozanimod-analyst-blog-2015-04-17", "https://www.nasdaq.com/articles/astrazenecas-onglyza-label-needs-revision-per-fda-panel-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/mercks-keytruda-tops-melanoma-lung-cancer-studies-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/athersys-slumps-as-multistem-fails-in-mid-stage-study-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/bristol-myers-study-on-opdivo-halted-on-early-success-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/oncolytics-reolysin-gets-one-more-orphan-drug-status-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/trovagenes-trov-pcm-data-impresses-shares-rally-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-jumps%3A-stock-moves-up-16.2-tale-of-the-tape-2015-04-17", "https://www.nasdaq.com/articles/aveo-up-on-pipeline-news-q4-loss-narrower-than-expected-analyst-blog-2015-03-09", "https://www.nasdaq.com/articles/the-medicines-co.s-kengreal-backed-for-fda-approval-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-6-2015-spls-fl-big-cmrx-gpt-sxe-kvhi-mrcc-vtg-aveo-2015", "https://www.nasdaq.com/articles/aveo-gains-on-tivozanib-agreement-with-ophthotech-analyst-blog-2014-11-13", "https://www.nasdaq.com/articles/will-aveo-pharmaceuticals-aveo-surprise-this-earnings-analyst-blog-2014-11-05", "https://www.nasdaq.com/articles/aveo-biodesix-reveal-lung-cancer-study-exploratory-data-analyst-blog-2014-10-02", "https://www.nasdaq.com/articles/biomed-leases-space-to-baxter-for-rd-center-in-ma-analyst-blog-2014-09-30", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-shares-march-higher-can-it-continue-tale-of-the-tape-2014-08-21", "https://www.nasdaq.com/articles/tuesday-sector-laggards-cigarettes-tobacco-drugs-2014-07-15", "https://www.nasdaq.com/articles/health-care-sector-update-03092015-aveohtbxacrx-2015-03-09", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-aveo-pharmaceuticals-aveo-tale-of-the-tape-2014-06-26", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-catches-eye%3A-stock-up-11.4-tale-of-the-tape-2014-06-18", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-inc.-aveo-in-focus%3A-stock-rises-7.8-tale-of-the-tape-2014-06-10", "https://www.nasdaq.com/articles/ptc-therapeutics-up-on-positive-chmp-opinion-analyst-blog-2014-05-27", "https://www.nasdaq.com/articles/sarepta-to-acquire-manufacturing-facility-analyst-blog-2014-05-23", "https://www.nasdaq.com/articles/narrower-than-expected-loss-at-aveo-analyst-blog-2014-05-08", "https://www.nasdaq.com/articles/aveo-biodesix-ink-deal-analyst-blog-2014-04-11", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-jumps%3A-stock-rises-6.4-tale-of-the-tape-2014-07-01", "https://www.nasdaq.com/articles/aveo-regains-av-203-rights-from-biogen-analyst-blog-2014-03-21", "https://www.nasdaq.com/articles/healthcare-stocks-undercut-earlier-market-advance-gilead-sciences-sinks-after-congress", "https://www.nasdaq.com/articles/aveo-q4-loss-narrower-than-expected-analyst-blog-2014-03-14", "https://www.nasdaq.com/articles/biotech-stock-roundup-regenerons-eylea-impresses-gilead-files-next-hcv-drug-analyst-blog", "https://www.nasdaq.com/articles/aveo-astellas-terminate-agreement-analyst-blog-2014-02-18", "https://www.nasdaq.com/articles/aveo-astellas-terminate-tivozanib-trial-analyst-blog-2014-01-31", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-inc.-aveo-catches-eye%3A-stock-rises-8-tale-of-the-tape-2013-12-31", "https://www.nasdaq.com/articles/aveo-pharmaceuticals-aveo-jumps%3A-stock-rises-7.2-tale-of-the-tape-2014-03-24", "https://www.nasdaq.com/articles/aveo-q3-loss-wider-than-expected-shares-down-analyst-blog-2013-11-12", "https://www.nasdaq.com/articles/wild-card-wonders-shopping-52-week-lows-2013-09-28", "https://www.nasdaq.com/articles/sleepy-sector-wakes-billionaires-hold-biotechs-52-week-low-2013-09-03", "https://www.nasdaq.com/articles/merrimack-undervalued-because-misunderstanding-and-miscommunication-2013-08-15", "https://www.nasdaq.com/articles/aveo-pharma-cuts-q2-loss-analyst-blog-2013-08-14", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-higher-stereotaxis-drops-43-q2-results-2013-08-08", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-08", "https://www.nasdaq.com/articles/aveo-falls-on-tivozanib-news-analyst-blog-2013-12-16", "https://www.nasdaq.com/articles/aveo-q3-loss-wider-than-expected-shares-down-analyst-blog-2013-11-12", "https://www.nasdaq.com/articles/wild-card-wonders-shopping-52-week-lows-2013-09-28", "https://www.nasdaq.com/articles/sleepy-sector-wakes-billionaires-hold-biotechs-52-week-low-2013-09-03", "https://www.nasdaq.com/articles/merrimack-undervalued-because-misunderstanding-and-miscommunication-2013-08-15", "https://www.nasdaq.com/articles/aveo-pharma-cuts-q2-loss-analyst-blog-2013-08-14", "https://www.nasdaq.com/articles/weekly-ceo-buys-highlight-aveo-zaza-tues-tues-fran-akva-2012-12-16", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-10-23", "https://www.nasdaq.com/articles/crl-for-aveo-alpmys-tivozanib-analyst-blog-2013-06-12", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-2012-10-10", "https://www.nasdaq.com/articles/xoma-enrolls-for-gevokizumab-trials-analyst-blog-2012-07-06", "https://www.nasdaq.com/articles/aveos-av-203-in-phase-i-analyst-blog-2012-05-24", "https://www.nasdaq.com/articles/bearish-macd-for-aveo-pharmaceuticals-inc.-tale-of-the-tape-2012-05-07", "https://www.nasdaq.com/articles/are-analysts-too-optimistic-about-these-stocks-short-sellers-think-so-2011-09-12", "https://www.nasdaq.com/articles/2-picks-investment-pro-20-annual-gains-2011-02-22", "https://www.nasdaq.com/articles/top-12-ipos-2010-can-they-go-higher-2010-10-19", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-2012-10-17"], "Content": []}